[Parkinson's syndrome. 10. Effects of psychopharmacological agents on central monoamine neurons].
作者信息
Roos B E
出版信息
Lakartidningen. 1970 Oct 14;67(42):4840-1.
PMID:4320249
Abstract
摘要
相似文献
1
[Parkinson's syndrome. 10. Effects of psychopharmacological agents on central monoamine neurons].[帕金森综合征。10. 精神药理药物对中枢单胺能神经元的影响]
Lakartidningen. 1970 Oct 14;67(42):4840-1.
2
Drug therapy of parkinsonism.
N Engl J Med. 1972 Jul 6;287(1):20-4. doi: 10.1056/NEJM197207062870105.
3
[l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].[左旋多巴治疗帕金森综合征及抗精神病药物的作用机制]
Med Klin. 1969 Aug 15;64(33):1451-6.
4
Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.帕金森病治疗的最新进展：单胺氧化酶抑制剂的应用
Expert Rev Neurother. 2005 Nov;5(6):811-21. doi: 10.1586/14737175.5.6.811.
5
Parkinson's disease; modern treatment.帕金森病；现代治疗方法
Minn Med. 1973 Jun;56(6):497-502.
6
[Other trials with drug therapy in parkinsonism].[帕金森病药物治疗的其他试验]
Tidsskr Nor Laegeforen. 1973 Oct 10;93(28):2115-7.
7
8
[Treatment of Parkinson's syndrome with L-dopa].[左旋多巴治疗帕金森综合征]
Schweiz Med Wochenschr. 1970 May 9;100(19):805-13.
9
Milacemide therapy for Parkinson's disease.米拉美胺治疗帕金森病
Mov Disord. 1993;8(1):47-50. doi: 10.1002/mds.870080109.
10
Elucidating the mechanism of action and potential interactions of MAO-B inhibitors.阐明单胺氧化酶B抑制剂的作用机制及潜在相互作用。
Neurol Clin. 2008 Aug;26(3 Suppl):S85-96, vi. doi: 10.1016/j.ncl.2008.05.002.
引用本文的文献
1
Monoamine reuptake inhibitors in Parkinson's disease.单胺再摄取抑制剂在帕金森病中的应用。
Parkinsons Dis. 2015;2015:609428. doi: 10.1155/2015/609428. Epub 2015 Feb 25.
Zotero 插件